Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Propanc Biopharma Inc (PPCB)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTHER OTC]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTHER OTC]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 1,349
  • Shares Outstanding, K 21,180
  • Annual Sales, $ 0 K
  • Annual Income, $ -7,870 K
  • 36-Month Beta 6.86
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book N/A
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.56
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date 05/25/18
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.0600 +6.83%
on 04/26/18
0.0900 -28.78%
on 05/03/18
+0.0029 (+4.74%)
since 04/25/18
3-Month
0.0530 +20.94%
on 04/11/18
0.1500 -57.27%
on 03/14/18
-0.0564 (-46.80%)
since 02/23/18
52-Week
0.0530 +20.94%
on 04/11/18
1.4200 -95.49%
on 05/31/17
-1.0659 (-94.33%)
since 05/25/17

Most Recent Stories

More News
New Report Released on Growing Biotech Sector

FN Media Group Presents Microcapspeculators.com News Commentary

DRNA : 13.77 (-0.15%)
PPCHD : 1.2000 (+20.00%)
IONS : 44.85 (-0.84%)
PPCB : 0.0641 (+0.63%)
CASI : 6.79 (-2.72%)
INSM : 27.61 (+0.77%)
Companies that Stand to Benefit from the Biotech Market Bottoming

FN Media Group Presents Microcapspeculators.com News Commentary

SRNE : 7.85 (-1.26%)
CELG : 78.63 (-1.14%)
CBAY : 11.36 (-7.27%)
ECYT : 13.33 (-5.19%)
PPCB : 0.0641 (+0.63%)
Propanc Biopharma Completes Scientific Advice Meeting with MHRA

MELBOURNE, Australia , April 10, 2018 /PRNewswire/ --  Propanc Biopharma Inc. (OTCQB: PPCB) ("Propanc Biopharma" or the "Company"), a clinical stage biopharmaceutical company focusing on development...

PPCB : 0.0641 (+0.63%)
Propanc Biopharma Completes Scientific Advice Meeting with MHRA

Propanc Biopharma Inc. (OTCQB: PPCB) ("Propanc Biopharma" or the "Company"), a clinical stage biopharmaceutical company focusing on development of new and proprietary treatments for cancer patients suffering...

PPCHD : 1.2000 (+20.00%)
PPCB : 0.0641 (+0.63%)
Biotech Market Poised to Reach 2015 Highs

FN Media Group Presents Microcapspeculators.com News Commentary

PPCHD : 1.2000 (+20.00%)
INNT : 13.38 (-5.17%)
PPCB : 0.0641 (+0.63%)
ONCS : 1.67 (+5.03%)
GERN : 4.70 (-2.49%)
LPTX : 8.54 (-0.70%)
Biotechnology Companies with Great Potential

LAS VEGAS, March 16, 2018 /PRNewswire/ --

JAZZ : 165.02 (+0.88%)
PPCB : 0.0641 (+0.63%)
GILD : 67.38 (-0.22%)
AMGN : 178.24 (+0.16%)
BIIB : 286.21 (+0.63%)
Propanc Biopharma Completes Successful Reproduction Run for PRP

MELBOURNE, Australia , March 14, 2018 /PRNewswire/ --  Propanc Biopharma Inc. (OTCQB: PPCB) ("Propanc Biopharma" or the "Company"), a clinical stage biopharmaceutical company focusing on development...

PPCB : 0.0641 (+0.63%)
The Story Behind Growth: New Report Discusses Propanc Health Group and Mexus Gold US - Emerging Trends Within New Industry

NEW YORK, NY / ACCESSWIRE / March 7, 2018 / Latest key findings by Growth Market Report for all traders, shareholders, and investors of Propanc Health Group Corp. (OTCQB: PPCB) and Mexus Gold US (OTCQB:...

PPCH : 1.3950 (+8.14%)
PPCB : 0.0641 (+0.63%)
MXSG : 0.0180 (+9.09%)
Propanc Biopharma Receives Allowance of Key Patent Application in the EU

MELBOURNE, Australia , Feb. 20, 2018 /PRNewswire/ --  Propanc Biopharma Inc. (OTCQB: PPCB) ("Propanc Biopharma" or the "Company"), a clinical stage biopharmaceutical company focusing on development...

PPCB : 0.0641 (+0.63%)
How CEO's of Biotech are Incentivized and What This Means for Investors

FN Media Group Presents Microcapspeculators.com News Commentary

ESPR : 37.54 (-0.40%)
PPCB : 0.0641 (+0.63%)
KURA : 17.05 (-0.87%)
JUNO : 86.96 (+0.10%)
VSTM : 5.38 (-6.11%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Sell with a Average short term outlook on maintaining the current direction.

Longer term, the trend strength is Weak. Long term indicators fully support a continuation of the trend.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Trade PPCB with:

Key Turning Points

2nd Resistance Point 0.0754
1st Resistance Point 0.0697
Last Price 0.0641
1st Support Level 0.0607
2nd Support Level 0.0574

See More

52-Week High 1.4200
Fibonacci 61.8% 0.8978
Fibonacci 50% 0.7365
Fibonacci 38.2% 0.5752
Last Price 0.0641
52-Week Low 0.0530

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
New Chart Menu
Right-click anywhere on the chart to open the Interactive Chart menu.

Free Barchart Webinar